Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

30 Mar 2020 07:00

RNS Number : 9488H
Numis Corporation PLC
30 March 2020
 

Numis Corporation Plc ("Numis")

Trading Update

 

 

Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the six month period ending 31 March 2020.

Numis is expected to report revenue approximately 10% higher than the first half of the prior year. The six month trading period commenced during a period of elevated political uncertainty and ended with global markets suffering significant declines in reaction to the COVID-19 pandemic. The window available to execute transactions during the first half was therefore limited, resulting in subdued Investment Banking deal volumes for the period although this was partially offset by an increase in our average fee. As such, Investment Banking revenues are expected to be marginally below the comparable period.

Equities delivered a materially stronger performance, more than offsetting the Investment Banking revenue decline. Execution revenues benefited from an improvement in activity levels subsequent to the UK General Election; this has been sustained through the current market volatility experienced in recent weeks. In addition our trading book performance has been strong across the period delivering gains materially ahead of the prior period. 

Operationally we responded to COVID-19 promptly and successfully implemented comprehensive remote working capability which has enabled us to ensure both the safeguarding of our staff and the ability to continue servicing our clients across the business throughout this period of uncertainty.

We are working closely with our corporate clients to assess the impact of COVID-19, and the unprecedented disruption that many of them are currently experiencing. Whilst it is too early to predict the timing of a recovery in our Investment Banking pipeline, we are committed to supporting our corporate clients as they consider any actions they may implement to insulate and protect their businesses amid such uncertainty.

Numis benefits from a strong liquidity and capital position. Our cash balance is currently higher than the position reported at year end, in addition we have an undrawn, committed credit facility of £35m. We believe that now, more than ever, our balance sheet strength, market expertise and our long term partnership approach, ensure we are well positioned to provide broad support to our corporate and institutional clients during these unprecedented times.

Due to the ongoing COVID-19 situation and in view of recent regulatory communications regarding financial reporting, the announcement date of Numis' half year results for the six months ending 31 March 2020 will be confirmed in due course.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014

 

Contacts:

Numis Corporation:

Alex Ham & Ross Mitchinson, Co-Chief Executives 020 7260 1245

Andrew Holloway, Chief Financial Officer 020 7260 1266

 

Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Harrison Clarke 020 7865 2411

Niall McDonald 020 7728 2347

 

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and employs approximately 280 staff in London and New York.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKOBDBBKBKNB
Date   Source Headline
23rd Jan 20171:00 pmRNSDirectors' Dealing
19th Jan 20172:00 pmRNSDirectors' Dealing
18th Jan 201711:00 amRNSDirector's Dealing
12th Jan 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jan 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20179:51 amRNSAnnual Report and Annual General Meeting Notice
3rd Jan 201710:38 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20163:00 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 201611:05 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSPreliminary Results for the year ended 30 Sep 2016
1st Dec 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 20162:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20162:00 pmRNSDirector's Dealing
27th Oct 20161:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Oct 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 201611:00 amRNSPurchase of shares in Close Period
3rd Oct 20167:00 amRNSTrading Update
14th Sep 20167:00 amRNSHolding(s) in Company
6th Sep 20169:45 amRNSDirector/PDMR Shareholding
5th Sep 20164:42 pmRNSGrant of Share Awards
22nd Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20163:11 pmRNSTransaction in Own Shares and Total Voting Rights
1st Aug 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Jul 201611:30 amRNSTransaction in Own Shares and Total Voting Rights
7th Jul 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20167:00 amRNSBoard Appointments
29th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 201612:07 pmRNSSecond Price Monitoring Extn
27th Jun 201612:02 pmRNSPrice Monitoring Extension
22nd Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jun 201611:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jun 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 201611:47 amRNSDirector's Dealing
24th May 20163:16 pmRNSPosting of Interim Report
23rd May 20163:00 pmRNSHolding(s) in Company
19th May 20162:12 pmRNSTransaction in Own Shares and Total Voting Rights
19th May 201610:00 amRNSTransfer of Shares from Treasury to EBT and TVR
13th May 20167:00 amRNSTransaction in Own Shares and Total Voting Rights
9th May 20169:39 amRNSTransfer of Shares from Treasury to EBT and TVR
6th May 20167:01 amRNSBoard Changes
6th May 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.